References
- Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992; 326(13):862–6
- Weitzman M, Gortmaker SL, Sobol AM, et al. Recent trends in the prevalence and severity of childhood asthma. JAMA 1992; 268(19):2673–7
- Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir J 1998; 12(5):1209–18
- Smith DH, Malone DC, Lawson KA, et al. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997; 156(3 Pt 1):787–93
- National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma: expert panel report II. Bethesda, Md: National Heart, Lung, and Blood Institute, 1997; NIH publication 97–4051
- Henry RL. All that coughs is not asthma. Pediatr Pulmonol 1999; 28(1):1–2
- Chang AB. Cough, cough receptors, and asthma in children. Pediatr Pulmonol 1999; 28(1):59–70
- Mathison DA. Asthma in adults. In: Middleton ED, ed. Allergy principles and practice. Vol 2. St Louis: Mosby Yearbook, 1998:901–26
- Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995; 151(4):969–74
- Horn CR, Clark TJ, Cochrane GM. Compliance with inhaled therapy and morbidity from asthma. Respir Med 1990; 84(1):67–70
- Clark N, Jones P, Keller S, et al. Patient factors and compliance with asthma therapy. Respir Med 1999; 93(12):856–62
- Barnes PJ. Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma. J Allergy Clin Immunol 1998; 101 (4 Pt 2):S427–33
- Suissa S, Ernst P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000; 343(5):332–6
- Woolcock A, Lundback B, Ringdal N, et al. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 153(5): 1481–8
- Louis R, Bettiol J, Cataldo D, et al. Theophylline decreases sputum eosinophilia of asthmatics. Int Arch Allergy Immunol 1999; 118(2–4):343–4
- Milgrom H, Fick RB, Su JQ, et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. N Engl J Med 1999; 341 (26): 1966–73
- Zhou CY, Crocker IC, Koening G, et al. Anti-interleukin-4 inhibits immunoglobulin E production in a murine model of atopic asthma. J Asthma 1997; 34(3):195–201
- Hamelmann E, Oshiba A, Loader J, et al. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am J Respir Crit Care Med 1997; 155(3):819–25
- Fahy JV, Liu J, Wong H, et al. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993; 147(5): 1126–31
- Sur S, Crotty TB, Kephart GM, et al. Sudden-onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 1993; 148(3):713–9
- Barnes PJ, Greening AP, Crompton GK. Glucocorticoid resistance in asthma. Am J Respir Crit Care Med 1995; 152(6 Pt 2):S125–40
- Hill JM, Tattersfield AE. Corticosteroid sparing agents in asthma. Thorax 1995; 50(5):577–82
- Hunt LW, Swedlund HA, Gleich GJ. Effect of nebulized lido- caine on severe glucocorticoid-dependent asthma. Mayo Clinic Proc 1996; 71(4):361–8